Coupang Faces Shifting Analyst Targets Amidst Fines

Coupang's fair value estimate has been adjusted downwards from US$26.29 to US$25.83, reflecting recent changes in analyst price targets. These revisions stem from updated earnings assumptions and the impact of tax and regulatory developments. Analysts are re-evaluating their models to account for these evolving factors and their influence on Coupang's medium-term financial outlook.

Despite the shifting targets, several Wall Street firms maintain optimistic stances. Goldman Sachs, for instance, upholds a Buy rating with a US$31 price target, considering tax assessments a manageable issue. Morgan Stanley also retains an Overweight rating and a US$28 target, noting that a finalized fine removes a significant uncertainty. BofA likewise keeps a Buy rating, adjusting its EPS view to reflect expected fine impacts.

Conversely, some analysts express a more cautious sentiment. Mizuho has lowered its price target to US$24 while maintaining a Neutral rating, indicating concerns over valuation amidst tax, regulatory, and currency effects. Barclays has cut its target to US$29, and prior downgrades from Deutsche Bank and Citi also signal apprehension regarding execution risks and the financial consequences of recent fines and back taxes.